Health Insurance Reimbursement: What Should Your Life Science Startup Know?

Andrew Mignatti (CEO, careviso) and Kari Timothy (VP of Sales, careviso) will demystify how insurers in the United States reimburse drugs, devices, and tests and the implications for U.S. startup companies innovating in the life sciences. They will address the mechanics of reimbursement, contracting with insurance providers, the prior authorization process, and other “black box” issues that often serve as barriers to the long-term success of new ventures.